A Profile of Avelumab Plus Axitinib in the Treatment of Renal Cell Carcinoma

Tiako Meyo M, Chen J, Goldwasser F, Hirsch L, Huillard O

Therapeutics and Clinical Risk Management 2022, 18:683-698

Published Date: 8 July 2022